SYNGENE384.00

Syngene International Ltd.

· Pharma & Health
₹ CrorePeersSAILIFEDIVISLABWOCKPHARMAGLANDASTERDMPPLPHARMACOHANCELALPATHLABMcap ₹15,471 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Non-current Assets
+ Property, Plant & Equipment2,378.32,322.62,545.42,545.4
+ Capital Work-in-Progress836.81,261.41,040.41,040.4
+ Investment Property41.134.331.531.5
+ Other Intangibles430.6444.8423.1423.1
+ Intangibles under Development1.34.75.35.3
+ Non-current Investments34.736.2285.0285.0
+ Other Non-current Financial Assets223.1215.9341.7341.7
Non-current Financial Assets257.8252.1626.7626.7
+ Deferred Tax Assets40.729.5100.7100.7
+ Other Non-current Assets206.0159.2138.8138.8
Total Non-current Assets4,192.64,508.64,911.94,911.9
Current Assets
+ Inventories238.5155.5141.3141.3
+ Current Investments513.2610.5456.1456.1
+ Trade Receivables441.6526.7508.8508.8
+ Cash & Cash Equivalents85.7367.1228.6228.6
+ Other Bank Balances477.8419.9604.4604.4
+ Other Current Financial Assets90.077.637.337.3
Current Financial Assets1,608.32,001.81,835.21,835.2
+ Other Current Assets112.2130.0166.3166.3
Total Current Assets1,959.02,287.32,142.82,142.8
Total Assets6,151.66,795.97,054.77,054.7
Equity
+ Equity Share Capital402.0402.5402.9402.9
+ Other Equity / Reserves3,855.74,324.34,436.24,436.2
Equity — Owners of Parent4,257.74,726.84,839.14,839.1
Total Equity4,257.74,726.84,839.14,839.1
Liabilities
+ Borrowings — Non-current100.00.00.00.0
+ Other Non-current Financial Liab365.1410.6447.4447.4
Non-current Financial Liabilities465.1410.6447.4447.4
+ Provisions — Non-current40.743.318.018.0
+ Other Non-current Liabilities243.8218.8197.9197.9
Non-current Liabilities749.6672.7663.3663.3
+ Borrowings — Current41.7119.69.49.4
+ Trade Payables255.5352.0347.5347.5
+ Other Current Financial Liab115.9125.5275.0275.0
Current Financial Liabilities413.1597.1631.9631.9
+ Provisions — Current72.771.3114.4114.4
+ Current Tax Liabilities47.68.427.727.7
+ Other Current Liabilities610.9719.6778.3778.3
Current Liabilities1,144.31,396.41,552.31,552.3
Total Liabilities1,893.92,069.12,215.62,215.6
Total Equity & Liabilities6,151.66,795.97,054.77,054.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current34.158.858.8
+ Dues to Other Creditors — Current317.9288.7288.7
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.